Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn L Schwienteck

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Drug and Alcohol Dependence|September 13, 2015
Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeysKathryn L Schwienteck, Matthew L Banks
Behavioural Pharmacology|September 14, 2018
Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeysKathryn L Schwienteck, S Stevens Negus, Matthew L Banks
Current Treatment Options in Psychiatry|May 27, 2015
Use of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine AddictionMatthew L Banks, Blake A Hutsell, Kathryn L Schwienteck, et al.
Journal of Neuroscience Methods|March 11, 2021
A drug-vs-food "choice" self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disordersE Andrew Townsend, Kathryn L Schwienteck, Hannah L Robinson, et al.
Psychopharmacology|April 3, 2017
Abuse-related effects of subtype-selective GABA<sub>A</sub> receptor positive allosteric modulators in an assay of intracranial self-stimulation in ratsKathryn L Schwienteck, Guanguan Li, Michael M Poe, et al.
Drug and Alcohol Dependence|September 4, 2019
Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexoneKathryn L Schwienteck, Steven Blake, Paul T Bremer, et al.
Neuropharmacology|January 21, 2019
Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female ratsKathryn L Schwienteck, Kaycee E Faunce, Kenner C Rice, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 23, 2017
N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse LiabilityErnesto Solis, John S Partilla, Farhana Sakloth, et al.
ACS Chemical Neuroscience|February 14, 2019
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder TreatmentSamuel Obeng, Abdulmajeed Jali, Yi Zheng, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Drug and Alcohol Dependence|September 13, 2015
Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeysKathryn L Schwienteck, Matthew L Banks
Behavioural Pharmacology|September 14, 2018
Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeysKathryn L Schwienteck, S Stevens Negus, Matthew L Banks
Current Treatment Options in Psychiatry|May 27, 2015
Use of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine AddictionMatthew L Banks, Blake A Hutsell, Kathryn L Schwienteck, et al.
Journal of Neuroscience Methods|March 11, 2021
A drug-vs-food "choice" self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disordersE Andrew Townsend, Kathryn L Schwienteck, Hannah L Robinson, et al.
Psychopharmacology|April 3, 2017
Abuse-related effects of subtype-selective GABA<sub>A</sub> receptor positive allosteric modulators in an assay of intracranial self-stimulation in ratsKathryn L Schwienteck, Guanguan Li, Michael M Poe, et al.
Drug and Alcohol Dependence|September 4, 2019
Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexoneKathryn L Schwienteck, Steven Blake, Paul T Bremer, et al.
Neuropharmacology|January 21, 2019
Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female ratsKathryn L Schwienteck, Kaycee E Faunce, Kenner C Rice, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 23, 2017
N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse LiabilityErnesto Solis, John S Partilla, Farhana Sakloth, et al.
ACS Chemical Neuroscience|February 14, 2019
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder TreatmentSamuel Obeng, Abdulmajeed Jali, Yi Zheng, et al.
Pageof 1